Comprehensive Health Assessment We conduct in-depth health evaluations , including lab testing and hormone assessments , to ensure that Semaglutide or Tirzepatide is safe and effective for you
Food and Drug Administration, serves as a critical pharmacovigilance tool for post-marketing surveillance of pharmaceutical products and therapeutic biologics 17
TRIUMPH-4 (Phase 3, 68 weeks) 12mg dose: 28.7% weight loss (~71 lbs / 32 kg average) 9mg dose: 26.4% weight loss (~64 lbs / 29 kg average) Patients also saw 76% reduction in knee osteoarthritis pain Blood pressure reduced by 14 mmHg on average Source: ClinicalTrials.gov (TRIUMPH-4, NCT05931367) The TRIUMPH Phase 3 program includes 4 trials studying retatrutide for obesity, type 2 diabetes, and cardiovascular outcomes
Some patients on Ozempic have reported relief from their existing mental health conditions such as major depressive disorder
Mouth sores are not listed as a recognised side effect in the UK Summary of Product Characteristics, and no established causal link exists based on current clinical evidence
What It Is A premium four-peptide blend in a single vial